AmgenvsU.S. Physical Therapy

AMGN and USPH stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$468.57

Value $253B

+0.63%
AMGN's page

USPH

U.S. Physical Therapy, Inc.

$99.67

Value $1.5B

+0.07%
USPH's page

Amgen (AMGN) has a market value of $253B and U.S. Physical Therapy (USPH) $1.5B. Over the last year, with dividends, AMGN moved +43.0% and USPH +42.7%. The P/E is 26.9 for AMGN and 50.0 for USPH. Dividend yield: AMGN 2.12%, USPH 1.84%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$253B

    USPH$1.5B

    AMGN is 168 times USPH

  • Revenue, 12 months

    AMGN$38.9B

    USPH$838M

    AMGN is 46 times USPH

  • Net income, 12 months

    AMGN$9.4B

    USPH$30M

    AMGN is 312 times USPH

  • Operating margin

    AMGN32.4%

    USPH9.1%

    23.3 points apart

  • ROIC

    AMGN16.2%

    USPH8.6%

    7.5 points apart

  • P/E

    AMGN26.9

    USPH50.0

    USPH is 1.9 times AMGN

  • Dividend yield

    AMGN2.1%

    USPH1.8%

    0.3 points apart

  • 5-year return

    AMGN+161.8%

    USPH+11.6%

    150.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+161.8%

USPH+11.6%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsUSPHWith dividends
1 year since November 14, 2025+43.0%Price +39.1%+42.7%Price +39.1%
3 years since November 16, 2023+89.1%+23.7% a yearPrice +74.2%+24.1%+7.5% a yearPrice +16.8%
5 years since November 15, 2021+161.8%+21.2% a yearPrice +125.9%+11.6%+2.2% a yearPrice +1.3%
10 years since November 16, 2016+325.7%+15.6% a yearPrice +218.3%+85.1%+6.4% a yearPrice +60.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenUSPHU.S. Physical Therapy

Valuation

AMGNUSPH
Valuation
Price$468.57$99.67
Market value$253B$1.5B
Enterprise value (EV)$293B$1.7B
P/E26.950.0
P/E, 5-year median23.048.2
P/B17.63.5
EV/EBIT23.322.5
Free cash flow yield3.8%4.6%

Results and growth

AMGNUSPH
Results and growth
Revenue, 12 months$38.9B$838M
Net income, 12 months$9.4B$30M
Free cash flow, 12 months$9.6B$69M
Earnings per share, 12 months$17.25-$1.34
Revenue growth, year on year10.0%16.3%
Revenue growth a year, past+7.6%over 5 years+13.1%over 5 years
EPS growth a year, past+2.9%over 5 years-10.5%over 5 years

Margins and returns on capital

AMGNUSPH
Margins and returns on capital
Gross margin70.9%18.9%
Operating margin32.4%9.1%
Net margin24.1%3.6%
ROIC16.2%8.6%
ROE87.8%6.5%

Balance sheet

AMGNUSPH
Balance sheet
Cash$13.2B$38M
Total debt$54.0B$420M
Net debt / EBITDA2.32.1
Interest cover4.8×–

Dividends and buybacks

AMGNUSPH
Dividends and buybacks
Dividend yield2.1%1.8%
Dividend per share, 12 months$9.94$1.83
Dividend growth a year, past+8.1%over 5 years–
Buyback yield–0.4%
Shareholder yield2.1%2.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or USPH

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or U.S. Physical Therapy?

By market value, Amgen ($253B) is about 167.6 times U.S. Physical Therapy ($1.5B), at today's prices.

How did AMGN and USPH stock do over the last 10 years?

Since November 16, 2016, AMGN's price moved +218.3% and USPH's +60.1%. With dividends: AMGN +325.7% (+15.6% a year), USPH +85.1% (+6.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or USPH?

The dividend yield at today's price is 2.12% for Amgen and 1.84% for U.S. Physical Therapy. Over the last twelve months they paid $9.94 and $1.83 per share.

What is the P/E of AMGN and USPH?

At today's price, the P/E is 26.9 for AMGN and 50.0 for USPH. The median of the last five years was 23.0 and 48.2, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or U.S. Physical Therapy?

Over the last twelve months, the net margin was 24.1% for Amgen and 3.6% for U.S. Physical Therapy, and the operating margin 32.4% and 9.1%. Revenue was $38.9B and $838M.

Which is the better investment, Amgen or U.S. Physical Therapy?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.